Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Apply
Izalontamab vs. Platinum-based Chemotherapy
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step